MOTS-c inhibits Osteolysis in the Mouse Calvaria by affecting osteocyte-osteoclast crosstalk and inhibiting inflammation.
Yan Z, Zhu S, Wang H et al. · Pharmacological research · PMID 31369811
Study summary
Main finding
MOTS-c reduced particle-associated bone erosion and inflammation. Cell experiments linked effects to osteocyte signaling, osteoclast formation, and AMPK-associated inflammatory pathways.
Mouse skull osteolysis model and bone-cell cultures
How the study was set up
A mouse particle-induced bone-erosion model was combined with osteocyte and bone-marrow-cell experiments.
What the researchers measured
Bone erosion, inflammation, OPG/RANKL balance, osteoclast formation, and stress-signaling pathways were assessed.
How to read this evidence
Researchers studied cells, isolated tissue, or animals. These experiments can help explain a mechanism, but do not establish benefits or safety in people. Human cells grown in a laboratory also belong in this category.
Results in context
The particles model a particular inflammatory bone-loss process. The findings do not establish clinical protection of joint replacements or treatment of human bone disease.
What this does not establish
Particle-induced mouse osteolysis and cultured cells do not establish human bone repair, implant outcomes, or administration safety.
Publication & source
Why this paper is included
The compound is a named subject of the publication title.
Publication indexing
Journal Article · Research Support, Non-U.S. Gov't